{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:55:06Z","timestamp":1789574106654,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.neurol.2020.03.020","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T20:51:11Z","timestamp":1593809471000},"page":"780-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metabolic\u00a0alterations in spinal and bulbar muscular atrophy"],"prefix":"10.1016","volume":"176","author":[{"given":"F.","family":"Francini-Pesenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Vitturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tresso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sorar\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2020.03.020_bib0350","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.18.7.671","article-title":"Progressive proximal spinal and bulbar muscular atrophy of late onset","volume":"18","author":"Kennedy","year":"1968","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.020_bib0355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2020.03.020_bib0360","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/ene.13850","article-title":"Insights into the genetic epidemiology of spinal and bulbar muscular atrophy: prevalence estimation and multiple founder haplotypes in the Veneto Italian region","volume":"26","author":"Bertolin","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0365","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0960-8966(99)00132-7","article-title":"Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families","volume":"10","author":"Mariotti","year":"2000","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2020.03.020_bib0370","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/archneur.57.1.109","article-title":"Amyotrophic lateral sclerosis mimic syndromes: a population-based study","volume":"57","author":"Traynor","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0375","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2017.07.005","article-title":"From gene to therapy in spinal and bulbar muscular atrophy: are we there yet?","volume":"465","author":"Pennuto","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0380","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ana.410440216","article-title":"Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy","volume":"844","author":"Li","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0385","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12031-015-0663-x","article-title":"Onset manifestations of spinal and bulbar muscular atrophy (Kennedy's disease)","volume":"58","author":"Finsterer","year":"2016","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neurol.2020.03.020_bib0390","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.neurol.2017.03.019","article-title":"Kennedy disease (X-linked recessive bulbospinal neuronopathy): a comprehensive review from pathophysiology to therapy","volume":"173","author":"Querin","year":"2017","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2020.03.020_bib0395","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","article-title":"Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy","volume":"82","author":"Cortes","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2020.03.020_bib0400","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nbd.2008.12.009","article-title":"Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy","volume":"34","author":"Johansen","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2020.03.020_bib0405","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jnnp-2015-311305","article-title":"Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients","volume":"87","author":"Querin","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.03.020_bib0410","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12031-015-0674-7","article-title":"Spinal and bulbar muscular atrophy","volume":"58","author":"Fischbeck","year":"2016","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neurol.2020.03.020_bib0415","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1212\/WNL.0000000000000434","article-title":"Brugada syndrome in spinal and bulbar muscular atrophy","volume":"82","author":"Araki","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.020_bib0420","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00415-014-7293-z","article-title":"Sleep disorders in spinal and bulbar muscular atrophy (Kennedy's disease): a controlled polysomnographic and self-reported questionnaires study","volume":"261","author":"Romigi","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0425","first-page":"11","article-title":"Decreased peak expiratory flow associated with muscle fibre-type switching in spinal and bulbar muscular atrophy","volume":"22","author":"Yamada","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2020.03.020_bib0430","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00415-018-8968-7","article-title":"Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease","volume":"266","author":"Breza","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0435","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/brain\/112.1.209","article-title":"X-linked recessive bulbospinal neuronopathy. A clinicopathological study","volume":"112","author":"Sobue","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2020.03.020_bib0440","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/mus.880181206","article-title":"X-linked recessive bulbospinal neuronopathy: clinical phenotypes and CAG repeat size in androgen receptor gene","volume":"18","author":"Shimada","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2020.03.020_bib0445","first-page":"3893","article-title":"A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length","volume":"87","author":"Dejager","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neurol.2020.03.020_bib0450","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1017\/S0317167100003486","article-title":"Neurologic course, endocrine dysfunction and triplet repeat size in spinal bulbar muscular atrophy","volume":"31","author":"Sinnreich","year":"2004","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neurol.2020.03.020_bib0455","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.neurol.2020.03.020_bib0460","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","article-title":"Pathogenesis of NASH: how metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease","volume":"1061","author":"Farrell","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0465","first-page":"285","article-title":"Clinical features of spinal and bulbar muscular atrophy","volume":"25","author":"Rhodes","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2020.03.020_bib0470","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00415-018-8790-2","article-title":"The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy","volume":"265","author":"Rosenbohm","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0475","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1572-0241.1999.01006.x","article-title":"The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating non-alcoholic steatohepatitis from alcoholic liver disease","volume":"94","author":"Sorbi","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0480","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1212\/WNL.0000000000004748","article-title":"Non-alcoholic fatty liver disease in spinal and bulbar muscular atrophy","volume":"89","author":"Guber","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.03.020_bib0485","first-page":"204","article-title":"Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of Italian patients with spinal-bulbar muscular atrophy","volume":"37","author":"Francini-Pesenti","year":"2018","journal-title":"Acta Myol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0490","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurol.2020.03.020_bib0495","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.bbadis.2014.08.004","article-title":"Non-alcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison?","volume":"1842","author":"Gruben","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neurol.2020.03.020_bib0500","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cmet.2012.07.004","article-title":"Selective insulin and leptin resistance in metabolic disorders","volume":"16","author":"Konner","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.neurol.2020.03.020_bib0505","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00415-017-8405-3","article-title":"Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy","volume":"264","author":"Nakatsuji","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0510","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MED.0b013e3283398ee2","article-title":"Androgens and obesity","volume":"17","author":"Allan","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.neurol.2020.03.020_bib0515","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1210\/jcem.86.9.7851","article-title":"The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer","volume":"86","author":"Smith","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.neurol.2020.03.020_bib0520","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2337\/dc10-2339","article-title":"Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes","volume":"34","author":"Wang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurol.2020.03.020_bib0525","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00125-002-0980-9","article-title":"The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men","volume":"46","author":"Zitzmann","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.neurol.2020.03.020_bib0530","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1530\/EJE-10-1022","article-title":"Androgen receptor CAG repeat length polymorphism modifies the impact of testosterone on insulin sensitivity in men","volume":"164","author":"M\u00f6hlig","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0535","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa1206168","article-title":"Gonadal steroids and body composition, strength, and sexual function in men","volume":"369","author":"Finkelstein","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2020.03.020_bib0540","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0026-0495(97)90299-7","article-title":"Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue","volume":"46","author":"Ramirez","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.neurol.2020.03.020_bib0545","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1152\/jappl.1989.66.1.498","article-title":"Effect of testosterone on muscle mass and muscle protein synthesis","volume":"66","author":"Griggs","year":"1989","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0550","first-page":"789653","article-title":"Androgens and adipose tissue in males: a complex and reciprocal interplay","author":"Mammi","year":"2012","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0555","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1467-789X.2012.01035.x","article-title":"Visceral fat and metabolic inflammation: the portal theory revisited","volume":"13","author":"Item","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.neurol.2020.03.020_bib0560","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.22252","article-title":"Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor","volume":"47","author":"Lin","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.neurol.2020.03.020_bib0565","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lfs.2014.06.007","article-title":"Testosterone\u00a0suppresses the expression of regulatory enzymes of\u00a0fatty\u00a0acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice","volume":"109","author":"Kelly","year":"2014","journal-title":"Life Sci"},{"key":"10.1016\/j.neurol.2020.03.020_bib0570","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1532-5415.2011.03472.x","article-title":"Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus","volume":"59","author":"Lee","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.neurol.2020.03.020_bib0575","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/hmg\/ddu445","article-title":"Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors","volume":"24","author":"Iida","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2020.03.020_bib0580","first-page":"381","article-title":"Testosterone\u00a0increases insulin-like growth factor-1 and insulin-like growth factor-binding protein","volume":"25","author":"Ashton","year":"1995","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.neurol.2020.03.020_bib0585","first-page":"S3","article-title":"Fundamental aspects of hypogonadism in the aging male","volume":"5","author":"Matsumoto","year":"2003","journal-title":"Rev Urol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0590","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2119\/molmed.2012.00271","article-title":"Insulin like growth factor (IGF)-1","volume":"18","author":"Rinaldi","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.neurol.2020.03.020_bib0595","article-title":"Insulin-like growth factor (IGF) system in\u00a0liver\u00a0diseases","volume":"27","author":"Adamek","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurol.2020.03.020_bib0600","doi-asserted-by":"crossref","first-page":"e1002321","DOI":"10.1371\/journal.pgen.1002321","article-title":"Macroautophagy is regulated by the UPR-mediator CHOP and accentuates the phenotype of SBMA mice","volume":"7","author":"Yu","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.neurol.2020.03.020_bib0605","first-page":"1087","article-title":"Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients","volume":"15","author":"Borgia","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurol.2020.03.020_bib0610","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/brain\/awl096","article-title":"Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients","volume":"129","author":"Atsuta","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2020.03.020_bib0615","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","article-title":"Management of NAFLD: a stage-based approach","volume":"13","author":"Rinella","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.neurol.2020.03.020_bib0620","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1017\/S0007114515002093","article-title":"Low-grade inflammation, diet composition and health: current research evidence and its translation","volume":"114","author":"Minihane","year":"2015","journal-title":"Br J Nutr"},{"key":"10.1016\/j.neurol.2020.03.020_bib0625","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/nu10010062","article-title":"Adherence to the\u00a0Mediterranean diet\u00a0and inflammatory markers","volume":"10","author":"Sureda","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.neurol.2020.03.020_bib0630","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12944-016-0286-4","article-title":"The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia","volume":"15","author":"Backes","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.neurol.2020.03.020_bib0635","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2020.03.020_bib0640","first-page":"415","article-title":"Ezetimibe therapy: mechanism of action and clinical update","volume":"8","author":"Phan","year":"2012","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.neurol.2020.03.020_bib0645","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.nut.2014.11.018","article-title":"Vitamin E has a beneficial effect on non-alcoholic fatty liver disease: a meta-analysis of randomised controlled trials","volume":"31","author":"Sato","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.neurol.2020.03.020_bib0650","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with non-alcoholic steatohepatitis","volume":"30","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2020.03.020_bib0655","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomised, placebo-controlled trial of pioglitazone in non-diabetic subjects with non-alcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neurol.2020.03.020_bib0660","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.bbrc.2016.08.043","article-title":"Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders","volume":"483","author":"Agarwal","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurol.2020.03.020_bib0665","doi-asserted-by":"crossref","first-page":"e013927","DOI":"10.1136\/bmjopen-2016-013927","article-title":"Pioglitazone\u00a0and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis","volume":"7","author":"Liao","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.neurol.2020.03.020_bib0670","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.2337\/dcS13-2035","article-title":"Guideline approach to therapy in patients with newly diagnosed type 2 diabetes","volume":"36","author":"Raz","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neurol.2020.03.020_bib0675","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/dom.13592","article-title":"Of mice and men: is there a future for\u00a0metformin\u00a0in the treatment of hepatic steatosis?","volume":"21","author":"Green","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.neurol.2020.03.020_bib0680","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.neurol.2020.03.020_bib0685","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cpt.105","article-title":"Anti-inflammatory strategies to prevent diabetic cardiovascular disease","volume":"98","author":"Jialal","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.neurol.2020.03.020_bib0690","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fphar.2018.00851","article-title":"Pioglitazone\u00a0protects against renal ischemia-reperfusion injury via the amp-activated protein kinase regulated autophagy pathway","volume":"9","author":"Chen","year":"2018","journal-title":"Front Pharmacol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720305920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720305920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:40:37Z","timestamp":1758519637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378720305920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0035378720305920"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2020.03.020","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic\u00a0alterations in spinal and bulbar muscular atrophy","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2020.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}